Macro shot of dozator tip and plastic plate for immunosorbent assay, molecular  diagnostics

RSV

Doctor do pulmonary percussion to patient boy to heal RSVFollowing the same strategy as for HIV and HRV, Viravaxx develops VXD003, its multiplexed diagnostic device for RSV. The test will be based on recombinant G and F coat proteins of the virus as well as a library of overlapping peptides of these proteins covering genotypes A and B. Once completed, the device will be able to fully characterize patients’ immune response to RSV infections.

It may be available for the research market during 2018.